Gladstone Institutional Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Buy |
19,204
+1,857
| +11% | +$1.45M | 0.62% | 33 |
|
|
2025
Q1 | $14.3M | Buy |
17,347
+1,290
| +8% | +$1.07M | 0.67% | 30 |
|
|
2024
Q4 | $12.4M | Sell |
16,057
-60
| -0.4% | -$46.3K | 0.58% | 34 |
|
|
2024
Q3 | $14.3M | Buy |
16,117
+4,607
| +40% | +$4.08M | 0.7% | 32 |
|
|
2024
Q2 | $10.4M | Buy |
11,510
+158
| +1% | +$143K | 0.54% | 36 |
|
|
2024
Q1 | $8.83M | Sell |
11,352
-899
| -7% | -$699K | 0.48% | 41 |
|
|
2023
Q4 | $7.14M | Sell |
12,251
-48
| -0.4% | -$28K | 0.4% | 60 |
|
|
2023
Q3 | $6.61M | Buy |
12,299
+286
| +2% | +$154K | 0.43% | 51 |
|
|
2023
Q2 | $5.63M | Sell |
12,013
-390
| -3% | -$183K | 0.34% | 75 |
|
|
2023
Q1 | $4.26M | Sell |
12,403
-1,593
| -11% | -$547K | 0.28% | 100 |
|
|
2022
Q4 | $5.12M | Sell |
13,996
-1,576
| -10% | -$577K | 0.36% | 67 |
|
|
2022
Q3 | $5.04M | Buy |
15,572
+973
| +7% | +$315K | 0.39% | 55 |
|
|
2022
Q2 | $4.73M | Buy |
14,599
+3,032
| +26% | +$983K | 0.37% | 63 |
|
|
2022
Q1 | $3.31M | Buy |
11,567
+9,582
| +483% | +$2.74M | 0.22% | 119 |
|
|
2021
Q4 | $548K | Sell |
1,985
-2,837
| -59% | -$783K | 0.04% | 364 |
|
|
2021
Q3 | $1.11M | Buy |
4,822
+3,550
| +279% | +$820K | 0.11% | 219 |
|
|
2021
Q2 | $292K | Sell |
1,272
-4,268
| -77% | -$980K | 0.03% | 404 |
|
|
2021
Q1 | $1.04M | Buy |
+5,540
| New | +$1.04M | 0.16% | 141 |
|
|
2020
Q1 | – | Sell |
-1,753
| Closed | -$231K | – | 302 |
|
|
2019
Q4 | $231K | Buy |
+1,753
| New | +$231K | 0.06% | 235 |
|
|
2019
Q3 | – | Sell |
-1,850
| Closed | -$205K | – | 293 |
|
|
2019
Q2 | $205K | Buy |
+1,850
| New | +$205K | 0.06% | 256 |
|